medroxyprogesterone has been researched along with Bone Diseases, Metabolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagur, A; Ghiringhelli, G; Mautalen, C; Vega, E; Wittich, A | 1 |
| Araujo, GL; Domingo, P; Fajreldines, F; Giglione, F; Noriega, R; Rivoira, MA; Ulla, MR | 1 |
2 other study(ies) available for medroxyprogesterone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.
Topics: Adult; Aged; Body Height; Body Weight; Bone Density; Bone Diseases, Metabolic; Densitometry; Drug Tolerance; Estradiol; Estrogen Replacement Therapy; Female; Femur; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Spine | 1996 |
[Effects on bone mass of oral alendronate, hormone replacement therapy and combined regimes in post-menopausal women: preliminary report on a comparative study].
Topics: Aged; Alendronate; Analysis of Variance; Bone Density; Bone Diseases, Metabolic; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Middle Aged; Prospective Studies | 1997 |